Hypertrophic cardiomyopathy: An inheritable disease;Hypertrofische cardiomyopathie: Een genetisch overdraagbare hartziekte

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 15, 2002, Pages 705-712

  Van Dockum, W G ^a   Doevendans, P A F M ^a   Van Rossum, A C ^a   Wilde, A A M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATOR; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENOTYPE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART VENTRICLE FUNCTION; HEREDITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE CONTRACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SARCOMERE; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; GENOTYPE; HUMANS; NETHERLANDS; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 0037070713     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review
2. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy
3. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: Asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet
4. The management of hypertrophic cardiomyopathy
5. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population
6. New diagnostic options in hypertrophic cardiomyopathy
7. Hypertrofische cardiomyopathic; bij wie en waarom genetisch onderzoek
8. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
9. Molecular basis of familial cardiomyopathies
10. Hypertrophic cardiomyopathy and its markers in the general population. The great masquerader revisited: The Framingham study
11. Prevalence of hypertrophic cardiomyopathy in a general population of young adults
12. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (I)
13. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2)
14. Van gen naar ziektc; basisbegrippen
15. Familial hypertrophic cardiomyopathy: From mutations to functional defects
16. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms
17. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening
18. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
19. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy
20. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation
21. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy
22. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy
23. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy
24. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families
25. Evaluation of right ventricular early diastolic filling by cine nuclear magnetic resonance imaging in patients with hypertrophic cardiomyopathy
26. Human heart: Tagging with MR imaging - A method for noninvasive assessment of myocardial motion
27. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging
28. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy
29. Regional heterogeneity of function in hypertrophic cardiomyopathy
30. Hypertrophic cardiomyopathy: Do we have the algorithm for life and death?
31. Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations
32. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome
33. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy
34. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
35. Presymptomatisch onderzoek na plotselinge hartdood in de familie
36. B-myosin heavy chain gene mutations in FHC families with sudden cardiac death
37. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population
38. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
39. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
40. Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypcrtrophic cardiomyopathy
41. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
42. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy